{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:25:24Z","timestamp":1793805924457,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,19]],"date-time":"2027-08-19T00:00:00Z","timestamp":1818633600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011249","name":"Robert H Lurie Comprehensive Cancer Center of Northwestern University","doi-asserted-by":"publisher","award":["P50CA180995"],"award-info":[{"award-number":["P50CA180995"]}],"id":[{"id":"10.13039\/100011249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["HT9425-25-1-0498"],"award-info":[{"award-number":["HT9425-25-1-0498"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.urolonc.2026.06.027","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:38:06Z","timestamp":1784806686000},"page":"515-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of MRI and site variation on surgical treatment for prostate cancer"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5993-6415","authenticated-orcid":false,"given":"Mitchell M.","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridwan","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton","family":"Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Bentrem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam B.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiten D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.urolonc.2026.06.027_bib0001","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.urolonc.2026.06.027_bib0002","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"issue":"10071","key":"10.1016\/j.urolonc.2026.06.027_bib0003","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.urolonc.2026.06.027_bib0004","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.urolonc.2026.06.027_bib0005","doi-asserted-by":"crossref","first-page":"236","DOI":"10.6004\/jnccn.2023.0014","article-title":"NCCN Guidelines\u00ae insights: prostate cancer early detection, version 1.2023: featured updates to the NCCN guidelines","volume":"21","author":"Moses","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.027_bib0006","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/JU.0000000000003492","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part II: considerations for a prostate biopsy","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.06.027_bib0007","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.06.027_bib0008","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41391-022-00543-4","article-title":"Real-world use of MRI for risk stratification prior to prostate biopsy","volume":"26","author":"Siddiqui","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2026.06.027_bib0009","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41391-024-00896-y","article-title":"Trends in pre-biopsy MRI usage for prostate cancer detection, 2007\u20132022","volume":"28","author":"Soerensen","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.urolonc.2026.06.027_bib0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.eururo.2021.06.026","article-title":"Effects of magnetic resonance imaging targeting on overdiagnosis and overtreatment of prostate cancer","volume":"80","author":"Vickers","year":"2021","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2026.06.027_bib0011","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/cncr.32709","article-title":"Downgrading of grade group 2 intermediate-risk prostate cancer from biopsy to radical prostatectomy: comparison of outcomes and predictors to identify potential candidates for active surveillance","volume":"126","author":"Su","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2026.06.027_bib0012","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.eururo.2024.02.003","article-title":"Does overgrading on targeted biopsy of magnetic resonance imaging-visible lesions in prostate cancer lead to overtreatment?","volume":"86","author":"Baboudjian","year":"2024","journal-title":"Eur Urol"},{"issue":"13","key":"10.1016\/j.urolonc.2026.06.027_bib0013","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/cncr.32821","article-title":"Impact of prebiopsy magnetic resonance imaging on biopsy and radical prostatectomy grade concordance","volume":"126","author":"Shoag","year":"2020","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2026.06.027_bib0014","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.euo.2023.04.004","article-title":"Impact of Magnetic resonance imaging targeting on pathologic upgrading and downgrading at prostatectomy: a systematic review and meta-analysis","volume":"6","author":"Weinstein","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"8","key":"10.1016\/j.urolonc.2026.06.027_bib0015","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.06.027_bib0016","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","article-title":"Negative predictive value of multiparametric Magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and Data System era: a systematic review and meta-analysis","volume":"78","author":"Sathianathen","year":"2020","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2026.06.027_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2025.02.013","article-title":"Prostate magnetic resonance imaging to predict grade concordance, extra prostatic extension, and biochemical recurrence after radical prostatectomy","volume":"43","author":"Huang","year":"2025","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.06.027_bib0018","article-title":"Prostate MRI and clinicopathologic risk calculator to predict laterality of extraprostatic extension at radical prostatectomy","author":"Li","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"10.1016\/j.urolonc.2026.06.027_bib0019","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/JU.0000000000004498","article-title":"Negative predictive value of a prostate MRI in black men: implications for biopsy decision-making","volume":"213","author":"Sandlow","year":"2025","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2026.06.027_bib0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/pros.24687","article-title":"Implementation of PSMA PET\/CT and alignment of ordering to SNMMI appropriate use criteria in a large network system","volume":"84","author":"Bennett","year":"2024","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.027_bib0021","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1464-410X.2011.10422.x","article-title":"The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up","volume":"109","author":"Antonarakis","year":"2012","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.urolonc.2026.06.027_bib0022","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1464-410X.2010.09594.x","article-title":"Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy","volume":"107","author":"Walz","year":"2011","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.urolonc.2026.06.027_bib0023","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.06.027_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2022.10.012","article-title":"MRI versus non-MRI diagnostic pathways before radical prostatectomy: impact on nerve-sparing, positive surgical margins, and biochemical recurrence","volume":"41","author":"Patel","year":"2023","journal-title":"Urol Oncol"},{"issue":"21","key":"10.1016\/j.urolonc.2026.06.027_bib0025","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.2018.5616","article-title":"Use of conservative management for low-risk prostate cancer in the Veterans Affairs Integrated Health Care system from 2005 to 2015","volume":"319","author":"Loeb","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2026.06.027_bib0026","article-title":"Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, part II: principles of active surveillance, principles of surgery, and follow-up","author":"Eastham","year":"2022","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.06.027_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.56600","article-title":"Health equity in the Veterans Health Administration from Veterans\u2019 Perspectives by race and sex","volume":"7","author":"Lee","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:26:40Z","timestamp":1793802400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926005879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1078143926005879"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.06.027","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of MRI and site variation on surgical treatment for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}